TGC Biomics

tgcBIOMICS is a Berlin-based biotechnology service and product company with deep expertise in microbiology and genetic engineering. It operates a hybrid business model, providing contract research and development (CRO-like services) while also commercializing its own proprietary research tools and diagnostic kits, primarily focused on Clostridium difficile. The company leverages its founders' academic pedigree in microbiology to serve research and diagnostic development markets, positioning itself as a specialized partner for complex protein production and infectious disease research. Its activities are supported by participation in EU-funded research projects, indicating collaborative innovation.

Proprietary bacterial (tgc) and eukaryotic expression system for heterologous protein production, encompassing genetic engineering, fermentation up to 30L, and advanced protein purification chromatography. Specialized capability for generating custom hybridoma cell lines and monoclonal antibodies.

tgcBIOMICS competes in the custom service segment against other boutique CROs and in the research reagents segment against large distributors (e.g., Thermo Fisher, Merck) and specialist antibody producers. Its main competitive advantage is deep, founder-led expertise in C. difficile and the ability to produce complex bacterial toxins and related proteins that are challenging for standard providers.